Stockreport

Evommune Announces Pricing of its Initial Public Offering

Evommune, Inc.  (EVMN) 
PDF PALO ALTO, Calif., Nov. 5, 2025 /PRNewswire/ -- Evommune, Inc. ("Evommune"), a clinical-stage biotechnology company developing innovati [Read more]